OraSure Technologies Inc. (NASDAQ:OSUR) CEO Douglas A. Michels sold 30,893 shares of the stock in a transaction that occurred on Wednesday, November 23rd. The shares were sold at an average price of $9.02, for a total value of $278,654.86. Following the sale, the chief executive officer now owns 731,898 shares of the company’s stock, valued at approximately $6,601,719.96. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Shares of OraSure Technologies Inc. (NASDAQ:OSUR) opened at 8.44 on Tuesday. The company has a market cap of $470.36 million, a P/E ratio of 28.13 and a beta of 1.50. The firm has a 50 day moving average price of $7.92 and a 200-day moving average price of $7.50. OraSure Technologies Inc. has a 12 month low of $5.09 and a 12 month high of $9.05.

OraSure Technologies (NASDAQ:OSUR) last released its earnings results on Wednesday, November 2nd. The company reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.04. The business had revenue of $32.25 million for the quarter, compared to the consensus estimate of $31.45 million. OraSure Technologies had a return on equity of 10.27% and a net margin of 13.70%. OraSure Technologies’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.03 earnings per share. Analysts anticipate that OraSure Technologies Inc. will post $0.29 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “OraSure Technologies Inc. (OSUR) CEO Douglas A. Michels Sells 30,893 Shares” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The legal version of this report can be viewed at https://www.thecerbatgem.com/2016/11/29/orasure-technologies-inc-osur-ceo-douglas-a-michels-sells-30893-shares.html.

Several analysts recently weighed in on the company. Canaccord Genuity restated a “buy” rating and set a $10.00 target price on shares of OraSure Technologies in a research note on Monday. BTIG Research downgraded OraSure Technologies from a “buy” rating to a “neutral” rating and set a $8.00 target price for the company. in a research note on Monday, September 19th. TheStreet upgraded OraSure Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, August 30th. Jefferies Group restated a “buy” rating and set a $10.00 target price (up previously from $8.00) on shares of OraSure Technologies in a research note on Wednesday, August 31st. Finally, Stephens upgraded OraSure Technologies from an “equal weight” rating to an “overweight” rating in a research note on Monday, August 29th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $8.58.

Hedge funds have recently added to or reduced their stakes in the stock. Walleye Trading LLC increased its stake in OraSure Technologies by 61.9% in the second quarter. Walleye Trading LLC now owns 18,300 shares of the company’s stock worth $108,000 after buying an additional 7,000 shares in the last quarter. Stevens Capital Management LP increased its stake in OraSure Technologies by 15.9% in the third quarter. Stevens Capital Management LP now owns 14,514 shares of the company’s stock worth $116,000 after buying an additional 1,995 shares in the last quarter. Springbok Capital Management LLC increased its stake in OraSure Technologies by 126.7% in the first quarter. Springbok Capital Management LLC now owns 16,300 shares of the company’s stock worth $118,000 after buying an additional 9,110 shares in the last quarter. Janney Montgomery Scott LLC increased its stake in OraSure Technologies by 3.2% in the second quarter. Janney Montgomery Scott LLC now owns 18,824 shares of the company’s stock worth $121,000 after buying an additional 579 shares in the last quarter. Finally, Eagle Global Advisors LLC bought a new stake in OraSure Technologies during the third quarter worth about $131,000. 81.91% of the stock is currently owned by institutional investors and hedge funds.

About OraSure Technologies

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

5 Day Chart for NASDAQ:OSUR

Receive News & Stock Ratings for OraSure Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies Inc. and related stocks with our FREE daily email newsletter.